Riskpilot← Back to searchSign inGet full accessThermo Fisher Diagnostics ApS
APSActiveCVR 27640745Gydevang 33Wholesale of other machinery and equipment · NACE 4664Est. 200426 employees
Revenue 2024
DKK 27,6M
-12% vs 2023
EBITDA margin
34.5%
-14% vs 2023
Equity ratio
49.1%
Financial strength
Net profit 2024
DKK 6,4M
-4% vs 2023
| Revenue | DKK 27,6M | -12% |
| EBITDA | DKK 9,5M | -14% |
| Net profit | DKK 6,4M | -4% |
| Total assets | DKK 141,4M | +9% |
| Equity | DKK 69,4M | +10% |
| Employees | 26 | — |
Legal name
Thermo Fisher Diagnostics ApS
CVR number
27640745
Legal form
Anpartsselskab
NACE code
4664 · Wholesale of other machinery and equipment
Founded
10. marts 2004
Share capital
DKK 125.000
Employees
26 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør.
Company purpose
Selskabets formål er at drive handelsvirksomhed med laboratorieudstyr og reagenser.
Address
Gydevang 33
Phone
+4532957150
Email
bjarne.kristensen@phadia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 34.651 | 33.084 | 44.114 | 31.409 | 27.565 |
| Staff expenses | -24.234 | -27.464 | -21.849 | -20.420 | -18.046 |
| EBITDA | 10.417 | 5.540 | 20.408 | 11.090 | 9.519 |
| Depreciation & amort. | -3.626 | -3.795 | -3.634 | -3.622 | -3.461 |
| EBIT | 6.791 | 1.745 | 16.774 | 7.468 | 6.058 |
| Net financials | -381 | -249 | -662 | 981 | 1.810 |
| Profit before tax | 6.410 | 1.496 | 16.112 | 8.449 | 7.868 |
| Tax | 1.408 | 331 | 3.550 | 1.849 | 1.510 |
| Net profit | 5.002 | 1.165 | 12.562 | 6.600 | 6.358 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 77.865 | 116.081 | 92.727 | 130.040 | 141.425 |
| Equity | 42.664 | 43.893 | 56.455 | 63.055 | 69.413 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 34.154 | 70.951 | 34.810 | 65.297 | 141.710 |
| Total debt | 34.154 | 70.951 | 34.810 | 65.297 | 141.710 |
EBITDA margin
34.5%
This company
15.8%
Market median
+118% vs market
20202024
Equity ratio
49.1%
This company
38.2%
Market median
+29% vs market
20202024
Return on equity
9.2%
This company
18.4%
Market median
-50% vs market
20202024
Net profit margin
23.1%
This company
8.1%
Market median
+185% vs market
20202024
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
20202024
Debt / equity
1.04×
This company
0.62×
Market median
-68% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Founder | 2004 | |
PF Management | Management | 2024 |
| Former (5) | ||
NX Management | Management | 2004 – 2004 |
SP Management | Management | 2008 – 2012 |
MC Management | Management | 2004 – 2004 |
BK Management | Management | 2004 – 2024 |
MH Management | Management | 2004 – 2008 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2012 | |
| Former (3) | ||
| Board of Directors | 2012 – 2020 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Thermo Fisher Diagnostics ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Newton Xavier Aguiar | Management | 0 companies |
| Santiago Pulido Verde | Management | 0 companies |
| Matthew Charles Turner | Management | 0 companies |
| DIA DIAGNOSTICS SWEDEN HOLDING AB Reg. nr. 556653-9796 | Founder | 0 companies |
| Pia Finnemann-Andersen | Management | 0 companies |
| Bjarne Kristensen | Management | 0 companies |
| Maria Holmlund | Management | 0 companies |
| Simon Lie | Board of Directors | 0 companies |
| Grant Hellier Lawrence | Board of Directors | 0 companies |
| Petrus Thomas Adrianus van der Zande | Chairman | 0 companies |
| Bo Kühnel Matthisson | Board of Directors | 0 companies |
| Michael Toftvad | Board of Directors | 0 companies |